GlaxoSmithKline Plc's (NYSE: GSK) Q1 turnover reached £9.78 billion, up 32% Y/Y on actual exchange rate AER and constant exchange rate CER basis.Specialty Medicines turnover...
GlaxoSmithKline Plc's (NYSE: GSK) Q1 turnover reached £9.78 billion, up 32% Y/Y on actual exchange rate AER and constant exchange rate CER basis.Specialty Medicines turnover was...
(Reuters) – British drugmaker GSK on Wednesday beat analyst expectations for its first-quarter profit and sales, ahead of the planned listing of its large consumer healthcare...
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.
A better than forecast, but still 2nd highest ever, UK borrowing figure for April failed to move the needle for the FTSE on Tuesday. The UK index was unchanged after the bell, flat...
The US is packing a lot into the final week of April, including a Fed meeting, some key Q1 data, and a stacked earnings calendar. USThere are a few major events this week,...
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Sell | Neutral | Strong Buy |
| Technical Indicators | Sell | Neutral | Strong Sell | Sell | Strong Buy |
| Summary | Sell | Neutral | Strong Sell | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 6.70 | 6.70 | 6.70 | -0.40 | -5.63% | 12.57M | London | |||
| 156.60 | 156.60 | 153.30 | +1.40 | +0.90% | 3.81M | London | |||
| 143.50 | 143.90 | 141.70 | +0.10 | +0.07% | 3.09M | London | |||
| 76.00 | 76.00 | 76.00 | -4.00 | -5.00% | 21.05K | London | |||
| 760.00 | 761.80 | 735.80 | -18.40 | -2.36% | 4.69M | London | |||
| 133.20 | 133.40 | 131.40 | +0.80 | +0.60% | 11.41M | London | |||
| 1,375.00 | 1,402.00 | 1,317.00 | -6.0 | -0.43% | 454.64K | London | |||
| 1,686.00 | 1,721.50 | 1,675.00 | -31.5 | -1.83% | 644.89K | London | |||
| 255.10 | 257.20 | 251.50 | -11.00 | -4.13% | 24.66M | London | |||
| 0.475 | 0.475 | 0.475 | 0.000 | 0.00% | 644.15K | London | |||
| 209.10 | 212.00 | 207.30 | -2.50 | -1.18% | 27.14M | London | |||
| 51.40 | 52.05 | 49.84 | -0.85 | -1.63% | 973.59K | London | |||
| 242.50 | 270.00 | 240.30 | -12.50 | -4.90% | 2.11M | London | |||
| 19.50 | 19.50 | 19.00 | -0.85 | -4.36% | 956.18K | London | |||
| 116.00 | 116.00 | 111.95 | -0.95 | -0.81% | 7.11M | London |